Skip to content

Study on efficacy of Caucasian whortleberry in treatment of type 2 diabetic patients

Study on efficacy of Vaccinium arctostaphylos (L.) fruits extract in treatment of type 2 diabetic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138902292288N3
Enrollment
60
Registered
2010-06-12
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Non-insulin-dependent diabetes mellitus type 2

Interventions

Intervention 1: Caucasian whortleberry fruits extract, one 500 mg capsule every 8 hours in addition to the oral synthetic antidiabetic drugs for 2 months. Intervention 2: One placebo capsule every 8 h
Treatment - Drugs
Placebo
Caucasian whortleberry fruits extract, one 500 mg capsule every 8 hours in addition to the oral synthetic antidiabetic drugs for 2 months
One placebo capsule every 8 hours in addition to the oral synthetic antidiabetic drugs for 2 months

Sponsors

Research Institute for Islamic and Complementary Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: type 2 diabetic patients, patients aged 40 to 60 years, patients with fasting glucose serum levels between 200 and 250 mg/dl, patients with glycosylated hemoglobin blood levels between 6.5 to 8 percent, patients whose blood glucose levels are not within the normal range despite using a combination of oral synthetic antidiabetic drugs. Exclusion criteria: patients with cardiac, renal or hepatic diseases, concomitant infections, pregnant women, women planning pregnancy, breast-feeding women.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting glucose serum level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).;Glycosylated hemoglobin blood level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).

Secondary

MeasureTime frame
2 hours postprandial glucose serum level. Timepoint: 2 months. Method of measurement: Medical laboratory (kit).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Saeed Kianbakht

Institute of Medicinal Plants affiliated with the ACECR

kianbakht@imp.ac.ir, skianbakht@gmail.com+98 26 1476 4010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026